Poor infection control increase risk of reinfection with MDR or XDR-TB strains

V. Crudu, S. Ruch-Gerdes, S. Niemann, N. Moraru, L. Carchilan, V. Lesan, G. Blagodeteleva, E. Stratan (Chisinau, Republic Of Moldova; Borstel, Germany)

Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis
Session: Multidrug-resistant and extensively drug-resistant tuberculosis
Session type: Oral Presentation
Number: 350
Disease area: Respiratory infections

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Crudu, S. Ruch-Gerdes, S. Niemann, N. Moraru, L. Carchilan, V. Lesan, G. Blagodeteleva, E. Stratan (Chisinau, Republic Of Moldova; Borstel, Germany). Poor infection control increase risk of reinfection with MDR or XDR-TB strains. Eur Respir J 2010; 36: Suppl. 54, 350

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of the multidrug resistant TB in children with HIV infection
Source: Eur Respir J 2004; 24: Suppl. 48, 439s
Year: 2004

Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
Source: Eur Respir J, 55 (6) 1902383; 10.1183/13993003.02383-2019
Year: 2020



Bedaquiline in treatment of TB/HIV co-infection patients with extremely-drug resistance of MBT
Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis
Year: 2018

Treatment outcomes for multidrug-resistant tuberculosis (MDR-TB) patients in Africa
Source: Annual Congress 2011 - Multidrug-resistant tuberculosis
Year: 2011

Extensively drug-resistant tuberculosis (XDR-TB) treatment outcome. Cohort study
Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2010


Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
Source: Eur Respir J 2013; 41: 1393-1400
Year: 2013



Shortened multidrug-resistant tuberculosis treatment in settings with a high prevalence of ofloxacin resistance
Source: Eur Respir J, 50 (1) 1700598; 10.1183/13993003.00598-2017
Year: 2017



Multidrug-resistant TB in children with HIV infection
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


Extensively drug resistant tuberculosis (XDR TB) in a high income country: a report of four unrelated cases
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007



Prevalence of MDR and XDR tuberculosis among patients with failure of re-treatment course
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008

Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007


Tuberculosis in household contacts of multidrug-resistant tuberculosis patients
Source: Annual Congress 2011 - Multidrug-resistant tuberculosis
Year: 2011

Treatment outcomes of extensively-drug resistant tuberculosis (XDR-TB) patients in 20 countries
Source: Annual Congress 2012 - Pros and cons of MDR- and XDR-TB treatment
Year: 2012

Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013

Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran
Source: Eur Respir J 2004; 24: Suppl. 48, 657s
Year: 2004

Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
Source: Eur Respir J 2009; 33: 1085-1094
Year: 2009



Increasing incidence of fluoroquinolone resistant tuberculosis in Bombay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005


Analysis of antibiotic resistance and enterococcal infections of low respiratory infection on patients in hospital
Source: Eur Respir J 2003; 22: Suppl. 45, 450s
Year: 2003

Are multi-drug resistant (MDR) pathogens related to higher mortality in pneumonia?
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011